IP Library Granted Patent US 7,531,324
Granted Patent B2
US 7,531,324 · App. 11/531,557 · Granted May 12, 2009

Interferon-alpha polypeptides and conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,531,324
App. No.
11/531,557
Granted
May 12, 2009
Kind
B2
Abstract

The present invention provides interferon-alpha polypeptides and conjugates, and nucleic acids encoding the polypeptides. The invention also includes compositions comprising these polypeptides, conjugates, and nucleic acids; cells containing or expressing the polypeptides, conjugates, and nucleic acids; methods of making the polypeptides, conjugates, and nucleic acids; and methods of using the polypeptides, conjugates, and nucleic acids.

Claims (20)

1. An isolated or recombinant polynucleotide comprising a nucleic acid sequence which encodes a polypeptide having the sequence SEQ ID NO:13 or a sequence which differs from SEQ ID NO:13 in 1-8 amino acid positions, which comprises Ala or Leu at position 48 and optionally comprises a methionine at the N-terminus, which polypeptide exhibits antiviral activity.

2. The polynucleotide of claim 1 , comprising a nucleic acid sequence which encodes a polypeptide comprising the sequence SEQ ID NO:13.

3. The polynucleotide of claim 2 , comprising a nucleic acid sequence selected from SEQ ID NO:62, SEQ ID NO:63, SEQ ID NO:64, and SEQ ID NO:89.

4. An isolated host cell comprising the nucleic acid of claim 1 .

5. A vector comprising the polynucleotide of claim 1 .

6. The vector of claim 5 , which is an expression vector comprising the polynucleotide operably linked to a promoter.

7. An isolated host cell comprising the vector of claim 6 .

8. A composition comprising the polynucleotide of claim 1 and an excipient.

9. A method for preparing a polypeptide, the method comprising:

providing a culture comprising a host cell, the host cell comprising an expression vector comprising a promoter operably linked to the polynucleotide of claim 1 ,

culturing the culture under conditions which permit expression of the polypeptide, and

recovering the polypeptide.

10. The method of claim 9 , wherein the host cell is a glycosylating host cell.

11. The method of claim 9 , wherein the host cell is a bacterial host cell.

12. The method of claim 9 , wherein the bacterial host cell is E. coli.

13. The method of claim 12 , wherein the step of recovering the polypeptide comprises:

(a) isolating inclusion bodies (IB) comprising the polypeptide;

(b) solubilizing the IB, thereby obtaining unfolded polypeptide;

(c) refolding the unfolded polypeptide, thereby obtaining refolded polypeptide; and

(d) purifying the refolded polypeptide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2009
From: MAXYGEN, INC.
To: PERSEID THERAPEUTICS LLC.
Reel/Frame 023649/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2008
From: ROCHE PALO ALTO LLC
To: MAXYGEN, INC.
Reel/Frame 020556/0315 →